Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), bought 2,501,113 shares at $16.00 ($10.2M) on 2021-08-03, disclosed to the SEC on 2021-08-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,863,613 | $0 | 0.0% |
| 2 | $16.00 | 12,500 | $200K | 2.0% |
| 3 | $16.00 | 125,000 | $2.0M | 19.6% |
| 4 | $16.00 | 500,000 | $8.0M | 78.4% |
| Total | $4.08 avg | 2,501,113 | $10.2M | 100% |
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |